Wikidata

(Q63393035)

English

A Study to Evaluate the Long-term Safety and Tolerability of Lu AF20513 and the Antibody Response in Patients With Alzheimer's Disease (AD)

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
Interventional, Open-label, Multiple-immunization Extension Study on the Safety, Tolerability and Immunogenicity of Lu AF20513/Adjuvant in Patients With Alzheimer's Disease (English)
0 references
sponsor
Lundbeck
0 references
country
Austria
0 references
Finland
0 references
Sweden
0 references
start time
26 June 2018
0 references
end time
February 2022
0 references
number of participants
57
0 references
minimum age
60 year
0 references
maximum age
85 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63393035&oldid=2235077296"